Biochem/physiol Actions
Class IC antiarrhythmic agent; sodium channel blocker
Features and Benefits
This compound was developed by Medicis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Packaging
100 mg in glass bottle
25 mg in poly bottle
This product has met the following criteria: